ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IRON vs TNGX // ALTMAN Z-SCORE & DEBT/EQUITY

Disc Medicine Inc. (NASDAQ) VS. Tango Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: IRON 6 — TNGX 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRON VS. TNGX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IRON TNGX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -27.50% -28.90% +1.40 IRON /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -4.93% -3.68% -1.25 TNGX /fcf-yield <GO>
Operating Margin -22.90% -60.00% +37.10 IRON /operating-margins <GO>
Net Profit Margin -20.60% -60.00% +39.40 IRON /net-margins <GO>
Revenue Growth (YoY) 16.50% 48.30% -31.80 TNGX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE 26.00 26.00 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 5/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 62.4 46.9 +15.50 IRON /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 0.87 +0.03 IRON /macro-sensitivity <GO>
Forward P/E Multiple 20.0x 28.0x -8.00 IRON /forward-pe <GO>
Enterprise Scale & Market Cap $3.59B $3.83B -$242.1M TNGX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IRON REV TNGX REV IRON GROSS % TNGX GROSS % IRON FCF TNGX FCF
FY 2025 $660.9M $62.4M — — -$181.3M -$139.9M
FY 2024 $363.2M $42.1M — — -$94.4M -$132.3M
FY 2023 $255.2M $36.5M — — -$73.5M -$119.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRON // BETA 0.90
TNGX // BETA 0.87